newsfilter
← Latest News
GlobeNewswire·

ProKidney Appoints Kenneth Locke as Chief Technical Officer

WINSTON-SALEM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today